View in EDS

DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers.

Saved in:
Bibliographic Details
Title: DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers.
Authors: Huang TT; National Cancer Institute Bethesda United States., Nair JR; National Cancer Institute Bethesda, Maryland United States., Bowen C; National Cancer Institute Bethesda United States., Castro J; Accent Therapeutics (United States) Lexington, MA United States., Nousome D; National Institutes of Health Bethesda, Maryland United States., Nayak S; Accent Therapeutics (United States) Lexington, MA United States., Silver SJ; Accent Therapeutics (United States) Lexington, MA United States., Lee JM; National Cancer Institute BETHESDA, MD United States.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 24. Date of Electronic Publication: 2026 Mar 24.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41873535
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+TT%22">Huang TT</searchLink>; National Cancer Institute Bethesda United States.<br /><searchLink fieldCode="AU" term="%22Nair+JR%22">Nair JR</searchLink>; National Cancer Institute Bethesda, Maryland United States.<br /><searchLink fieldCode="AU" term="%22Bowen+C%22">Bowen C</searchLink>; National Cancer Institute Bethesda United States.<br /><searchLink fieldCode="AU" term="%22Castro+J%22">Castro J</searchLink>; Accent Therapeutics (United States) Lexington, MA United States.<br /><searchLink fieldCode="AU" term="%22Nousome+D%22">Nousome D</searchLink>; National Institutes of Health Bethesda, Maryland United States.<br /><searchLink fieldCode="AU" term="%22Nayak+S%22">Nayak S</searchLink>; Accent Therapeutics (United States) Lexington, MA United States.<br /><searchLink fieldCode="AU" term="%22Silver+SJ%22">Silver SJ</searchLink>; Accent Therapeutics (United States) Lexington, MA United States.<br /><searchLink fieldCode="AU" term="%22Lee+JM%22">Lee JM</searchLink>; National Cancer Institute BETHESDA, MD United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 Mar 24. <i>Date of Electronic Publication: </i>2026 Mar 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41873535
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-25-1196
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: DHX9 inhibition enhances paclitaxel sensitivity by inducing mitotic failure in ovarian and endometrial cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang TT
      – PersonEntity:
          Name:
            NameFull: Nair JR
      – PersonEntity:
          Name:
            NameFull: Bowen C
      – PersonEntity:
          Name:
            NameFull: Castro J
      – PersonEntity:
          Name:
            NameFull: Nousome D
      – PersonEntity:
          Name:
            NameFull: Nayak S
      – PersonEntity:
          Name:
            NameFull: Silver SJ
      – PersonEntity:
          Name:
            NameFull: Lee JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 03
              Text: 2026 Mar 24
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1